Finance

Lists
Why is 688192 up 4,93%?
Dive Deeper
688192:SHA
Dizal Pharmaceutical Co Ltd
62,60 CN¥
+4,93%
(+2,94) 1D
16 հոկ, 15:00:00 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688192...
Open
60,86 CN¥
High
65,30 CN¥
Low
60,86 CN¥
Mkt. cap
29,12 մլրդ
Avg. vol.
5,07 մլն
Volume
9,16 մլն
52-wk high
71,26 CN¥
52-wk low
35,73 CN¥
EPS
-1,29 CN¥
No. of employees
990
Open
60,86 CN¥
High
65,30 CN¥
Low
60,86 CN¥
Mkt. cap
29,12 մլրդ
Avg. vol.
5,07 մլն
Volume
9,16 մլն
52-wk high
71,26 CN¥
52-wk low
35,73 CN¥
EPS
-1,29 CN¥
No. of employees
990
News stories
From web sources and news partners
About Dizal Pharmaceutical Co Ltd
CEO-
Employees990
Founded27 հոկ, 2017 թ.
Headquarters-
Sector-
Websitedizalpharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
231,30 մլն
214,83 մլն
252,52 մլն
270,17 մլն
Cost of goods sold
9,70 մլն
8,90 մլն
10,29 մլն
10,60 մլն
Cost of revenue
9,70 մլն
8,90 մլն
10,29 մլն
10,60 մլն
Research and development expenses
235,97 մլն
211,37 մլն
187,80 մլն
214,23 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
201,88 մլն
190,93 մլն
158,81 մլն
160,08 մլն
Operating expense
395,84 մլն
447,15 մլն
338,22 մլն
381,36 մլն
Total operating expenses
405,54 մլն
456,05 մլն
348,51 մլն
391,96 մլն
Operating income
-174,24 մլն
-241,22 մլն
-95,99 մլն
-121,79 մլն
Other non operating income
-894,53 հզր
3,23 մլն
180,03 հզր
-218,18 հզր
EBT including unusual items
-203,91 մլն
-184,23 մլն
-96,34 մլն
-116,12 մլն
EBT excluding unusual items
-180,55 մլն
-248,71 մլն
-103,12 մլն
-130,21 մլն
Income tax expense
-
1,34 մլն
359,90 հզր
273,39 հզր
Effective tax rate
-
-0,73%
-0,37%
-0,24%
Other operating expenses
-42,46 մլն
44,68 մլն
-8,66 մլն
6,65 մլն
Net income
-202,59 մլն
-184,10 մլն
-95,56 մլն
-114,82 մլն
Net profit margin
-87,59%
-85,69%
-37,84%
-42,50%
Earnings per share
-
-
-
-
Interest and investment income
381,37 հզր
295,52 հզր
287,49 հզր
251,42 հզր
Interest expense
-6,44 մլն
-10,01 մլն
-7,60 մլն
-8,90 մլն
Net interest expenses
-6,06 մլն
-9,71 մլն
-7,31 մլն
-8,64 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-164,34 մլն
-230,35 մլն
-85,12 մլն
-105,97 մլն
Gain or loss from assets sale
279,00
-279,00
-
-84,07 հզր
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps